Results 251 to 260 of about 3,602,392 (295)

Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis. [PDF]

open access: yesSignal Transduct Target Ther
Liu X   +23 more
europepmc   +1 more source

The PCR revolution

European Journal of Cancer, 1992
cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res 1984,44,5427-5431. 51. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Sensitization of human melanoma cells to the cytotoxic effects of melphalan by the glutathione transferase inhibitor e-&crynic acid. CancerRes 1991,51,94-98. 52.
Alasdair C. Stamps   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy